Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
11 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biovaxys-announces-closing-of-third-tranche-of-private-placement-302245829.html
04 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biovaxys-to-present-new-data-on-its-dpx-immune-educating-platform-at-personalized-cancer-vaccine-summit-302237831.html
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biovaxys-dpx-based-vaccines-exhibit-robust-efficacy-across-multiple-infectious-diseases-302228589.html
19 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/spayvac-for-wildlife-inc-announces-completion-of-spayvac-research-and-production-facility-in-madison-wisconsin-302225118.html
29 Jul 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-07-29/biovaxys-partners-to-develop-dpx-based-therapy-for-food-allergies/9769
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biotheryx-announces-first-patient-dosed-in-phase-1-clinical-trial-of-btx-9341-a-first-in-class-dual-bifunctional-degrader-of-cdk46-as-a-monotherapy-and-in-combination-with-fulvestrant-for-hrher2--breast-cancer-302198738.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?